Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q1 2022 Earnings

28FebConfirmed

Q2 2021

Q3 2021

Q4 2021

Q1 2022

-0.51

-0.37

-0.23

-0.09

Details

Expected EPS

-0.25

Actual EPS

-0.27

Surprise EPS

-0.02

Surprise Percent

+8%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.27 per share for Q1 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.